Lopinavir Metabolite M-1(192725-39-6)
- Name: Lopinavir Metabolite M-1
- Synonyms:1(2H)-Pyrimidineacetamide,N-[(1S,3S,4S)-4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-a-(1-methylethyl)-2,4-dioxo-, (aS)- (9CI);1(2H)-Pyrimidineacetamide, N-[4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-a-(1-methylethyl)-2,4-dioxo-,[1S-[1R*(R*),3R*,4R*]]-
- Molecular Formula:C37H46 N4 O6
- Molecular Weight:642.792
- CAS Registry Number:192725-39-6
- EINECS:
- Melting Point:106-108°C
- Water Solubility:
CAS No.192725-39-6 (2S)-N-[(4S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-2-(2,4-dioxo-1,3-diazinan-1-yl)-3-methylbutanamide
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.192725-39-6 Lopinavir metabolite M1
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Transportation:express and sea transport and air freight Application:for drug impurity for drug standards,for drug research and development銆侱rug impurity reference, drug standard, analytical chemistry, standard substance, organic chemical synthesis, chemical custo...
Min. Order:25Milligram
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.192725-39-6 Lopinavir Metabolite M-1
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Lopinavir Metabolite M-1
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.192725-39-6 Lopinavir Metabolite M-1
Assay:97% Appearance:white crystals powder Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 192811-69-1/1H-1,2,4-Triazole-1-ethanamine,N-cyclopentyl-(9CI)
- 192811-51-1/Propanenitrile, 3-[(2-fluorophenyl)amino]- (9CI)
- 192811-37-3/N-PROPYL-TETRAHYDRO-2H-PYRAN-4-AMINE
- 192802-28-1/(S)-O-BENZYLLACTALDEHYDE-N-(TERT-BUTOXYCARBONYL)HYDRAZONE
- 192801-39-1/6-Benzothiazoleaceticacid,2-(hydroxymethyl)-(9CI)
- 192800-59-2/4-(3-Bromo-phenyl)-1,3-dihydro-imidazole-2-thione
- 192799-05-6/6-Bromo-5-chloro-1H-indole-2,3-dione
- 192770-68-6/1H-Indole-2-carboxylicacid,2,3-dihydro-1-nitroso-(9CI)
- 192752-76-4/2-Butanone, 3-(formyloxy)- (9CI)
- 192750-50-8/Glycine, N-(cyanomethyl)-N-(2-hydroxyethyl)- (9CI)
- 192726-52-6/Siloxanes and Silicones, di-Me, hydroxy-terminated, ethers with polyethylene-polypropylene glycol monoallyl ether
- 192725-90-9/Hydrazinecarboxylic acid, 2-(2-propenyl)-, 1,1-dimethylethyl ester (9CI)
- 192725-49-8/N-[(1S,2S,4S)-4-amino-2-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-2-(2,6-dimethylphenoxy)acetamide
- 192725-39-6/Lopinavir Metabolite M-1
- 192725-12-5/1,2-Acridinediol, 1,2-dihydro-, (1R,2S)- (9CI)
- 192723-42-5/MCA-PRO-LEU-ALA-GLN-ALA-VAL-DAP(DNP)-ARG-SER-SER-SER-ARG-NH2
- 192717-86-5/.beta.-D-Glucofuranoside, 4-nitrophenyl
- 192717-48-9/Cyclohexanone, 3-(3-pyridinyl)- (9CI)
- 192717-43-4/5-Isoxazolebutanol,3-methyl-(9CI)
- 192717-33-2/1H-Benzimidazole,5-(3-methoxy-1-propenyl)-(9CI)
- 192717-23-0/5-Isoxazolebutanal,3-methyl-(9CI)
- 192717-20-7/2-Propen-1-ol,3-(1H-benzimidazol-5-yl)-(9CI)
- 192717-18-3/Pyridine, 4-(oxiranyloxy)- (9CI)
- 192711-21-0/Pyridine, 1,2-dihydro-2-(3H-pyrazol-3-ylidene)- (9CI)
- 192707-40-7/2(3H)-Furanone,5-(2,3-dihydroxyphenyl)dihydro-4-methyl-,(4R,5S)-rel-(-)-(9CI)
- 192704-58-8/5,pregnane-7 alpha,21-dicarboxylic acid,17-ydroxy-11-methylsulfonic acid-3-ketone,-butyrolectone,methyl ester cas:(intermediate of eplerenone)
- 192702-78-6/Bicyclo[2.2.1]heptan-2-amine, 1,3,3-trimethyl-, (1R,4S)-[partial]- (9CI)